BDBM50044042 (S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-[(S)-2-[2-((S)-3,3-dimethyl-butyrylamino)-3-(1H-indol-3-yl)-propionylamino]-6-(3-o-tolyl-ureido)-hexanoylamino]-N-methyl-succinamic acid::CHEMBL319913

SMILES: CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC(C)(C)C

InChI Key: InChIKey=CITGVGHWOPZVLZ-BQYLNSIHSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50044042   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cholecystokinin receptor (Homo sapiens (Human))	BDBM50044042 ((S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-[(S)-2-[2...) Show SMILES CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC(C)(C)C Show InChI InChI=1S/C45H58N8O8/c1-28-15-9-11-19-32(28)52-44(61)47-22-14-13-21-34(41(58)51-36(25-39(55)56)43(60)53(5)37(40(46)57)23-29-16-7-6-8-17-29)50-42(59)35(49-38(54)26-45(2,3)4)24-30-27-48-33-20-12-10-18-31(30)33/h6-12,15-20,27,34-37,48H,13-14,21-26H2,1-5H3,(H2,46,57)(H,49,54)(H,50,59)(H,51,58)(H,55,56)(H2,47,52,61)/t34-,35-,36-,37-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	5.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
Abbott Laboratories Curated by ChEMBL					Assay Description Concentration required to inhibit 50% of specific binding to Cholecystokinin type B receptor in guinea pig cortex using [125I]Bolton-Hunter CCK-8				J Med Chem 37: 309-13 (1994) BindingDB Entry DOI: 10.7270/Q2445N4S
					More data for this Ligand-Target Pair
Cholecystokinin A receptor (Cavia porcellus)	BDBM50044042 ((S)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-[(S)-2-[2...) Show SMILES CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC(C)(C)C Show InChI InChI=1S/C45H58N8O8/c1-28-15-9-11-19-32(28)52-44(61)47-22-14-13-21-34(41(58)51-36(25-39(55)56)43(60)53(5)37(40(46)57)23-29-16-7-6-8-17-29)50-42(59)35(49-38(54)26-45(2,3)4)24-30-27-48-33-20-12-10-18-31(30)33/h6-12,15-20,27,34-37,48H,13-14,21-26H2,1-5H3,(H2,46,57)(H,49,54)(H,50,59)(H,51,58)(H,55,56)(H2,47,52,61)/t34-,35-,36-,37-/m0/s1	PDB MMDB Reactome pathway UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Abbott Laboratories Curated by ChEMBL					Assay Description Inhibition of [125I]Bolton-Hunter CCK-8 binding to cholecystokinin type A receptor in guinea pig pancreas				J Med Chem 37: 309-13 (1994) BindingDB Entry DOI: 10.7270/Q2445N4S
					More data for this Ligand-Target Pair